|
KIAA1797 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.433400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523420E-03 |
| Normal-vs-Stage2 |
1.701420E-01 |
| Normal-vs-Stage3 |
1.170420E-04 |
| Normal-vs-Stage4 |
2.04819999849448E-08 |
| Stage1-vs-Stage2 |
2.193600E-01 |
| Stage1-vs-Stage3 |
1.032550E-01 |
| Stage1-vs-Stage4 |
1.564870E-04 |
| Stage2-vs-Stage3 |
3.853700E-02 |
| Stage2-vs-Stage4 |
6.393100E-04 |
| Stage3-vs-Stage4 |
5.131900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13409999999525E-05 |
| Normal-vs-AfricanAmerican |
4.209000E-01 |
| Normal-vs-Asian |
9.419100E-03 |
| Caucasian-vs-AfricanAmerican |
6.086200E-02 |
| Caucasian-vs-Asian |
3.110600E-01 |
| AfricanAmerican-vs-Asian |
3.911400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38149999999271E-05 |
| Normal-vs-Female |
1.197440E-03 |
| Male-vs-Female |
2.807800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.966000E-04 |
| Normal-vs-Age(41-60Yrs) |
6.407400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.316480E-03 |
| Normal-vs-Age(81-100Yrs) |
2.050100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.624600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.052200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.837600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.888600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.581800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.551200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.821150E-03 |
| Classical-VS-Follicular |
2.085600E-01 |
| Classical-VS-Other |
1.378190E-01 |
| Classical-VS-Normal |
4.622300E-04 |
| Tall-VS-Follicular |
5.836600E-04 |
| Tall-VS-Other |
8.434000E-01 |
| Tall-VS-Normal |
5.83389999975203E-07 |
| Follicular-VS-Other |
6.264900E-03 |
| Follicular-VS-Normal |
5.307500E-02 |
| Other-VS-Normal |
2.296100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.917600E-03 |
| Normal-vs-N1 |
2.11039996589335E-09 |
| N0-vs-N1 |
2.51849999999276E-06 |
|
|
